OWP
FCSC

Obermeyer Wealth Partners’s Fibrocell Science Inc. FCSC Stock Holding History

Obermeyer Wealth Partners’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-333
Closed -$31K – 319
2013
Q2 		$31K Buy
+333
New +$27.5K 0.01% 159

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Obermeyer Wealth Partners's FCSC Position: Q3 2013 in Review

Obermeyer Wealth Partners sold out of Fibrocell Science Inc. (FCSC) in Q3 2013, closing a stake of 333 shares — an estimated $31K sold.

Obermeyer Wealth Partners first reported a position in FCSC in Q2 2013 and held it in 1 quarter. The position peaked at $31K in Q2 2013. 44 funds tracked by Wall St. Rank hold FCSC as of Q3 2013.

  • Obermeyer Wealth Partners reported no remaining Fibrocell Science Inc. position as of Q3 2013 after selling out during the quarter.
  • Obermeyer Wealth Partners sold 333 Fibrocell Science Inc. shares in Q3 2013, an estimated $31K.
  • Obermeyer Wealth Partners first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 1 quarter.
  • Obermeyer Wealth Partners's Fibrocell Science Inc. position peaked at $31K in Q2 2013.
  • 44 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2013.

Based on Obermeyer Wealth Partners's 13F filing for Q3 2013, filed 18 Oct 2013.